Avastin Second-Line Treatment Improves Survival Time

Continuing Avastin into second-line chemotherapy for advanced colorectal cancer when tumors begin to grow larger or new tumors appear (progression) improves both survival time and the time until further progression according to Phase III clinical trial results that will be reported this Sunday morning, June 3, at ASCO 2012 in Chicago Study results were previewed in…  Read More

Dr. Edith Mitchell Honored by ASCO

Edith Peterson Mitchell, MD, FACP has been honored with the 2012 ASCO Humanitarian Award. The Award is given to an oncologist who goes beyond the call of duty to provide outstanding patient care both professionally and and as a volunteer. Dr. Mitchell is a clinical professor in the department of Medical Oncology and a program leader…  Read More

Watch Out for Fake Adderall

The FDA is warning consumers about counterfeit Adderall advertised on the Internet. The fake pills are not made by Teva Pharmaceuticals, contain none of the active Adderall ingredients, and instead have ingredients that may be dangerous. Adderall is a stimulant approved by the FDA to treat attention deficit disorder and narcolepsy, but is occasionally prescribed off-label…  Read More

Have They Found a Better Colonoscopy Prep?

Ask almost anyone after their first colonoscopy, and they’ll tell you, “The procedure was nothing, but the prep was awful.” Now patients are reporting that combining MiraLAX®, an over-the-counter laxative, with 2 quarts of Gatorade tastes better and is easier to take than the standard 4-quart Golytely colonoscopy preparation. In a randomized clinical trial , almost…  Read More

Regorafenib Now Available Via Expanded Access

Click Here to Get updates from Fight Colorectal Cancer The first four sites where colorectal cancer patients can get regorafenib are now open.  Bayer Healthcare expects to open additional sites in the next two or three weeks. Colorectal cancer patients whose cancer has gotten worse on all standard treatments can now be considered for the Regorafenib…  Read More

Protect Kids from Fentanyl Pain Patches

The FDA reminds patients who use fentanyl patches for pain to take special care storing, using, and discarding them. Recently the FDA evaluated 26 cases of children’s accidents that involved the patches including 10 deaths and 12 hospitalizations. Sixteen children were under two years of age. Problems included curious children finding patches in the trash or…  Read More